List of Tables
Table 1. Global Low Molecular Weight Heparin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Low Molecular Weight Heparin Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Low Molecular Weight Heparin Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Low Molecular Weight Heparin Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Low Molecular Weight Heparin Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Low Molecular Weight Heparin Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Low Molecular Weight Heparin Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Low Molecular Weight Heparin Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Low Molecular Weight Heparin Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Low Molecular Weight Heparin Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Low Molecular Weight Heparin Injection, Product Type & Application
Table 12. Global Key Manufacturers of Low Molecular Weight Heparin Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Low Molecular Weight Heparin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Low Molecular Weight Heparin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Low Molecular Weight Heparin Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Low Molecular Weight Heparin Injection Sales Market Share by Region (2019-2024)
Table 19. Global Low Molecular Weight Heparin Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Low Molecular Weight Heparin Injection Sales Market Share by Region (2025-2030)
Table 21. Global Low Molecular Weight Heparin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Low Molecular Weight Heparin Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Low Molecular Weight Heparin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Low Molecular Weight Heparin Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Low Molecular Weight Heparin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Low Molecular Weight Heparin Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Low Molecular Weight Heparin Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Low Molecular Weight Heparin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Low Molecular Weight Heparin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Low Molecular Weight Heparin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Low Molecular Weight Heparin Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Low Molecular Weight Heparin Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Low Molecular Weight Heparin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Low Molecular Weight Heparin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Low Molecular Weight Heparin Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Low Molecular Weight Heparin Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Low Molecular Weight Heparin Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Low Molecular Weight Heparin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Low Molecular Weight Heparin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Low Molecular Weight Heparin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Low Molecular Weight Heparin Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Low Molecular Weight Heparin Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Low Molecular Weight Heparin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Low Molecular Weight Heparin Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Low Molecular Weight Heparin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Low Molecular Weight Heparin Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Low Molecular Weight Heparin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Low Molecular Weight Heparin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Low Molecular Weight Heparin Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Low Molecular Weight Heparin Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2019-2024)
Table 53. Global Low Molecular Weight Heparin Injection Sales Market Share by Type (2025-2030)
Table 54. Global Low Molecular Weight Heparin Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Low Molecular Weight Heparin Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Low Molecular Weight Heparin Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Low Molecular Weight Heparin Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Low Molecular Weight Heparin Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2019-2024)
Table 63. Global Low Molecular Weight Heparin Injection Sales Market Share by Application (2025-2030)
Table 64. Global Low Molecular Weight Heparin Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Low Molecular Weight Heparin Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Low Molecular Weight Heparin Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Aspen Company Information
Table 71. Aspen Description and Business Overview
Table 72. Aspen Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Aspen Low Molecular Weight Heparin Injection Product
Table 74. Aspen Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Low Molecular Weight Heparin Injection Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Pfizer Low Molecular Weight Heparin Injection Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Opocrin Company Information
Table 86. Opocrin Description and Business Overview
Table 87. Opocrin Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Opocrin Low Molecular Weight Heparin Injection Product
Table 89. Opocrin Recent Developments/Updates
Table 90. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 91. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 92. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Hebei Changshan Biochemical Pharmaceutical Low Molecular Weight Heparin Injection Product
Table 94. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 95. Jiangsu Wanbang Biopharmaceuticals Company Information
Table 96. Jiangsu Wanbang Biopharmaceuticals Description and Business Overview
Table 97. Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Jiangsu Wanbang Biopharmaceuticals Low Molecular Weight Heparin Injection Product
Table 99. Jiangsu Wanbang Biopharmaceuticals Recent Developments/Updates
Table 100. Tianjin Chasesun Pharmaceutical Company Information
Table 101. Tianjin Chasesun Pharmaceutical Description and Business Overview
Table 102. Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Tianjin Chasesun Pharmaceutical Low Molecular Weight Heparin Injection Product
Table 104. Tianjin Chasesun Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Qilu Pharmaceutical Low Molecular Weight Heparin Injection Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. He'nan Xuchang Huaren Pharmaceutical Company Information
Table 111. He'nan Xuchang Huaren Pharmaceutical Description and Business Overview
Table 112. He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. He'nan Xuchang Huaren Pharmaceutical Low Molecular Weight Heparin Injection Product
Table 114. He'nan Xuchang Huaren Pharmaceutical Recent Developments/Updates
Table 115. Hainan GT-Unipul Pharmaceutical Company Information
Table 116. Hainan GT-Unipul Pharmaceutical Description and Business Overview
Table 117. Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Hainan GT-Unipul Pharmaceutical Low Molecular Weight Heparin Injection Product
Table 119. Hainan GT-Unipul Pharmaceutical Recent Developments/Updates
Table 120. Kunming Jida Pharmaceutical Company Information
Table 121. Kunming Jida Pharmaceutical Description and Business Overview
Table 122. Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Kunming Jida Pharmaceutical Low Molecular Weight Heparin Injection Product
Table 124. Kunming Jida Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Low Molecular Weight Heparin Injection Distributors List
Table 128. Low Molecular Weight Heparin Injection Customers List
Table 129. Low Molecular Weight Heparin Injection Market Trends
Table 130. Low Molecular Weight Heparin Injection Market Drivers
Table 131. Low Molecular Weight Heparin Injection Market Challenges
Table 132. Low Molecular Weight Heparin Injection Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Low Molecular Weight Heparin Injection
Figure 2. Global Low Molecular Weight Heparin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Low Molecular Weight Heparin Injection Market Share by Type: 2023 & 2030
Figure 4. Low Molecular Weight Heparin Sodium Injection Product Picture
Figure 5. Low Molecular Weight Heparin Calcium Injection Product Picture
Figure 6. Global Low Molecular Weight Heparin Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Low Molecular Weight Heparin Injection Market Share by Application: 2023 & 2030
Figure 8. Treatment of Venous Thromboembolism
Figure 9. Complications of Pregnancy
Figure 10. Cardioversion of Atrial Fibrillation/Flutter
Figure 11. Others
Figure 12. Global Low Molecular Weight Heparin Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Low Molecular Weight Heparin Injection Market Size (2019-2030) & (US$ Million)
Figure 14. Global Low Molecular Weight Heparin Injection Sales (2019-2030) & (K Units)
Figure 15. Global Low Molecular Weight Heparin Injection Average Price (US$/Unit) & (2019-2030)
Figure 16. Low Molecular Weight Heparin Injection Report Years Considered
Figure 17. Low Molecular Weight Heparin Injection Sales Share by Manufacturers in 2023
Figure 18. Global Low Molecular Weight Heparin Injection Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Low Molecular Weight Heparin Injection Players: Market Share by Revenue in Low Molecular Weight Heparin Injection in 2023
Figure 20. Low Molecular Weight Heparin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Low Molecular Weight Heparin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Low Molecular Weight Heparin Injection Sales Market Share by Country (2019-2030)
Figure 23. North America Low Molecular Weight Heparin Injection Revenue Market Share by Country (2019-2030)
Figure 24. United States Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Low Molecular Weight Heparin Injection Sales Market Share by Country (2019-2030)
Figure 27. Europe Low Molecular Weight Heparin Injection Revenue Market Share by Country (2019-2030)
Figure 28. Germany Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Low Molecular Weight Heparin Injection Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Low Molecular Weight Heparin Injection Revenue Market Share by Region (2019-2030)
Figure 35. China Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Low Molecular Weight Heparin Injection Sales Market Share by Country (2019-2030)
Figure 43. Mexico Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Low Molecular Weight Heparin Injection Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Low Molecular Weight Heparin Injection Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Low Molecular Weight Heparin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Low Molecular Weight Heparin Injection by Type (2019-2030)
Figure 53. Global Revenue Market Share of Low Molecular Weight Heparin Injection by Type (2019-2030)
Figure 54. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Low Molecular Weight Heparin Injection by Application (2019-2030)
Figure 56. Global Revenue Market Share of Low Molecular Weight Heparin Injection by Application (2019-2030)
Figure 57. Global Low Molecular Weight Heparin Injection Price (US$/Unit) by Application (2019-2030)
Figure 58. Low Molecular Weight Heparin Injection Value Chain
Figure 59. Low Molecular Weight Heparin Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
